Target intelligence / Profile preview

Telomeric DNA damage response pathway (Telomeric DDR)

Target
Telomeric DDR
Molecular classification
Signaling pathway, DNA repair mechanism, Cell cycle checkpoint
01

Overview

The telomeric DNA damage response pathway represents a specialized branch of the cellular DNA damage response that operates specifically at telomeres, the protective structures at chromosome ends. This pathway involves a paradoxical relationship between telomere protection and DNA damage signaling[1][3].\n\nTelomeres are nucleoprotein structures that cap the ends of linear chromosomes, preventing them from being recognized as DNA double-strand breaks (DSBs)[1]. The shelterin protein complex, consisting of six proteins (TRF1, TRF2, POT1, RAP1, TPP1, and TIN2), plays a critical role in distinguishing telomeres from damaged DNA[6]. TRF2 and POT1 specifically suppress ATM- and ATR-mediated DNA damage response pathways, respectively[6][3].\n\nWhen telomeres become dysfunctional due to critical shortening or damage, they trigger a persistent DNA damage response that leads to cellular senescence[2]. Unlike typical DNA damage elsewhere in the genome, telomeric DNA damage appears to be irreparable, causing a prolonged checkpoint activation[2]. This persistent DDR at telomeres is a key contributor to aging and aging-related diseases[4].\n\nThe pathway involves several key kinases, including ATM (Ataxia Telangiectasia Mutated), ATR (Ataxia Telangiectasia and Rad3-related), and DNA-PK (DNA-dependent protein kinase)[1][6]. These kinases coordinate cell cycle arrest and DNA repair activities. At functional telomeres, these responses are suppressed, but they become activated at dysfunctional telomeres[5].\n\nInterestingly, many proteins involved in the general DNA damage response also localize to telomeres and participate in telomere homeostasis[5]. For example, the MRN complex (MRE11-RAD50-NBS1) plays roles in both DSB repair and telomere maintenance[4]. Additionally, RNA polymerase II is recruited to damaged telomeres where it synthesizes damage-induced long non-coding RNAs (dilncRNAs) that can be processed into DNA damage response RNAs (DDRNAs), which promote the formation of DNA damage response foci[4].\n\nThe telomeric DDR pathway has significant implications for cancer therapy, as cancer cells often manipulate telomere maintenance mechanisms to achieve replicative immortality[6]. Understanding this pathway provides opportunities for therapeutic intervention in both cancer and aging-related diseases[4].

Other names
Telomere-related DNA damage responseTelomere DDRTelomeric DNA damage signaling
02

Mechanism of action

Inhibition of DNA damage signaling at telomeres; Modulation of telomerase recruitment; Suppression of checkpoint activation; Prevention of telomere fusion events

03

Biological functions

DNA damage detection and repairCell cycle regulationCellular senescence inductionTelomere maintenanceGenome stability maintenanceReplication stress response
04

Disease associations

CancerAging-related diseasesTelomere biology disordersHutchinson-Gilford Progeria SyndromeGenomic instability disorders
05

Safety considerations

Potential genomic instabilityCellular senescence inductionCancer risk with pathway dysregulationAccelerated aging phenotypes
06

Interacting drugs

Telomerase inhibitors

3 more in the full profile.

07

Biomarkers

Telomere lengthDDR foci at telomeresTelomeric dilncRNA and DDRNA levelsShelterin complex protein expression

Beyond the preview

Go deeper on Telomeric DNA damage response pathway (Telomeric DDR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Telomeric DNA damage response pathway (Telomeric DDR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call